Dr. Hou is a clinical-investigator with a focus on health care delivery improvement for patients with Crohn's disease and ulcerative colitis. He has received federal funding (AHRQ, VA) to study care delivery patterns and optimal timing for colon cancer detection in patients Crohn's and colitis, and to compare the effectiveness and patient acceptance of biosimilar biologic medications for Crohn's and Colitis. Dr. Hou is a Deputy Director of IBD QORUS, a multi-center quality improvement program and learning healthcare system supported by the Crohn's and Colitis Foundation. He leads the development and implementation of care pathways for Crohn's and Colitis within IBD Qorus. Lastly, he is actively involved in Phase 2 and 3 clinical trials for new therapeutic agents for Crohn's and Colitis.